203 related articles for article (PubMed ID: 24781496)
1. Blocking the mineralocorticoid receptor improves effectiveness of steroid treatment for low back pain in rats.
Ye L; Xie W; Strong JA; Zhang JM
Anesthesiology; 2014 Sep; 121(3):632-43. PubMed ID: 24781496
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor blocker eplerenone reduces pain behaviors in vivo and decreases excitability in small-diameter sensory neurons from local inflamed dorsal root ganglia in vitro.
Dong F; Xie W; Strong JA; Zhang JM
Anesthesiology; 2012 Nov; 117(5):1102-12. PubMed ID: 23023156
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid Receptor Antagonism Reduces Inflammatory Pain Measures in Mice Independent of the Receptors on Sensory Neurons.
Qualls KA; Xie W; Zhang J; Lückemeyer DD; Lackey SV; Strong JA; Zhang JM
Neuroscience; 2024 Mar; 541():64-76. PubMed ID: 38307407
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid Antagonist Improves Glucocorticoid Receptor Signaling and Dexamethasone Analgesia in an Animal Model of Low Back Pain.
Ibrahim SIA; Xie W; Strong JA; Tonello R; Berta T; Zhang JM
Front Cell Neurosci; 2018; 12():453. PubMed ID: 30524245
[TBL] [Abstract][Full Text] [Related]
5. Role of Na
Xie W; Zhang J; Strong JA; Zhang JM
Neuroscience; 2019 Mar; 402():51-65. PubMed ID: 30699332
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid Receptor, A Promising Target for Improving Management of Low Back Pain by Epidural Steroid Injections.
Ibrahim SIA; Strong JA; Zhang JM
J Anesth Perioper Med; 2016; 3(4):177-184. PubMed ID: 28956026
[TBL] [Abstract][Full Text] [Related]
7. Differential Regulation of the Glucocorticoid Receptor in a Rat Model of Inflammatory Pain.
Ibrahim SIA; Strong JA; Qualls KA; Ulrich-Lai YM; Zhang JM
Anesth Analg; 2020 Jul; 131(1):298-306. PubMed ID: 31990732
[TBL] [Abstract][Full Text] [Related]
8. Preclinical studies of low back pain.
Strong JA; Xie W; Bataille FJ; Zhang JM
Mol Pain; 2013 Mar; 9():17. PubMed ID: 23537369
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.
Hu X; Li S; McMahon EG; Lala DS; Rudolph AE
Mini Rev Med Chem; 2005 Aug; 5(8):709-18. PubMed ID: 16101407
[TBL] [Abstract][Full Text] [Related]
10. Localized Sympathectomy Reduces Mechanical Hypersensitivity by Restoring Normal Immune Homeostasis in Rat Models of Inflammatory Pain.
Xie W; Chen S; Strong JA; Li AL; Lewkowich IP; Zhang JM
J Neurosci; 2016 Aug; 36(33):8712-25. PubMed ID: 27535916
[TBL] [Abstract][Full Text] [Related]
11. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
12. Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.
Chadwick JA; Hauck JS; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA
Physiol Genomics; 2017 Jun; 49(6):277-286. PubMed ID: 28432191
[TBL] [Abstract][Full Text] [Related]
13. The respective and interaction effects of spinal GRs and MRs on radicular pain induced by chronic compression of the dorsal root ganglion in the rat.
Gu X; Peng L; Yang D; Ma Q; Zheng Y; Liu C; Zhu B; Song L; Sun X; Ma Z
Brain Res; 2011 Jun; 1396():88-95. PubMed ID: 21550593
[TBL] [Abstract][Full Text] [Related]
14. Bursting activity in myelinated sensory neurons plays a key role in pain behavior induced by localized inflammation of the rat sensory ganglion.
Xie W; Strong JA; Kim D; Shahrestani S; Zhang JM
Neuroscience; 2012 Mar; 206():212-23. PubMed ID: 22265726
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia.
Xie W; Strong JA; Ye L; Mao JX; Zhang JM
Pain; 2013 Aug; 154(8):1170-80. PubMed ID: 23622763
[TBL] [Abstract][Full Text] [Related]
16. Pro- versus Antinociceptive Nongenomic Effects of Neuronal Mineralocorticoid versus Glucocorticoid Receptors during Rat Hind Paw Inflammation.
Li X; Shaqura M; Mohamed D; Beyer A; Yamada S; Mousa SA; Schäfer M
Anesthesiology; 2018 Apr; 128(4):796-809. PubMed ID: 29356757
[TBL] [Abstract][Full Text] [Related]
17. Back pain and the mineralocorticoid receptor: is there a connection?
Schumacher MA
Anesthesiology; 2012 Nov; 117(5):951-2. PubMed ID: 23042224
[No Abstract] [Full Text] [Related]
18. Up-regulation of dorsal root ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitro study.
Lin YT; Ro LS; Wang HL; Chen JC
J Neuroinflammation; 2011 Sep; 8():126. PubMed ID: 21958434
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
[TBL] [Abstract][Full Text] [Related]
20. The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.
Eudy RJ; Sahasrabudhe V; Sweeney K; Tugnait M; King-Ahmad A; Near K; Loria P; Banker ME; Piotrowski DW; Boustany-Kari CM
J Transl Med; 2011 Oct; 9():180. PubMed ID: 22017794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
